Davis R M Inc. Trims Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Davis R M Inc. decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 23.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,308 shares of the company’s stock after selling 1,040 shares during the period. Davis R M Inc.’s holdings in Henry Schein were worth $229,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Versant Capital Management Inc increased its stake in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the period. Venturi Wealth Management LLC increased its stake in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC increased its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the period. Smartleaf Asset Management LLC increased its stake in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the period. Finally, City State Bank purchased a new stake in Henry Schein in the fourth quarter worth $55,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of HSIC stock opened at $69.94 on Thursday. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The stock’s 50-day moving average is $74.77 and its 200 day moving average is $72.64. The company has a market cap of $8.68 billion, a P/E ratio of 28.78, a PEG ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the business earned $0.66 EPS. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. Research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of recent research reports. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.